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OBJECTIVE — To assess whether nocturnal blood pressure dipping status in type 1 diabetes
is correlated with speciﬁc sleep characteristics and differences in nocturnal glycemic proﬁles.
RESEARCH DESIGN AND METHODS — Twenty type 1 diabetic adult patients un-
derwent sleep studies with simultaneous 24-h ambulatory blood pressure monitoring and con-
tinuous nocturnal glucose monitoring.
RESULTS — Altogether,55%ofpatientsexhibitedbluntedbloodpressuredipping.Theydid
notdifferfromthedippergroupinage,BMI,orsystolic(SBP)anddiastolic(DBP)bloodpressure.
Totalsleepperiod(TSP)washigherinthedippergroup(49730vs.40744minfordippers
and nondippers, respectively, P  0.001). TSP was correlated with SBP and DBP day-night
differences (r  0.44 and 0.49, respectively). Periods of nocturnal hypoglycemia (i.e., % of TSP
with glycemia 70 mg/dl) were longer in the dipper group (8.1  10.7 vs. 0.1  0.4% for
dippers and nondippers, respectively, P  0.02).
CONCLUSIONS — Dipping status in type 1 diabetes was associated with longer sleep du-
ration and with hypoglycemia unawareness.
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D
uringsleep,ambulatorybloodpres-
sure monitoring (ABPM) demon-
strates a normal decline of over
10% in blood pressure (BP), correspond-
ingtotheso-calleddippingstatus.Intype
1 diabetes, nondipping status is more
prevalent (1) and is associated with in-
creased risks for sustained hypertension,
retinopathy, and nephropathy (1–3).
Dipping pattern could be inﬂuenced by
sleep duration and associated sleep disor-
ders (4). In type 1 diabetes, sleep stability
impacts sleep-related hypoglycemia by
changing awakening responses to these
episodes (5). Our hypothesis was that
type 1 diabetic subjects with more stable
sleep could exhibit normal BP dip and,
because of higher arousal thresholds,
could present an increased frequency of
nocturnal hypoglycemia.
RESEARCH DESIGN AND
METHODS— We prospectively in-
vestigated22unselectedadult,male,type
1 diabetic patients who completed sleep
studies with simultaneous 24-h ABPM
and nocturnal continuous blood glucose
monitoringduringa24-hhospitalization.
Patients suffered from type 1 diabetes ac-
cordingtoAmericanDiabetesAssociation
criteria. Patients presenting with severe
uncontrolled hypertension (systolic BP
[SBP] 180 mmHg and/or diastolic BP
[DBP] 110 mmHg) were excluded.
Complete data were available for 20 pa-
tients. The study was approved by our
local ethics committee and registered in a
clinical trials database.
ABPM (Novacor, Rueil Malmaison,
France) was performed according to Eu-
ropean recommendations (6). To differ-
entiate daytime from nighttime BP,
analysis was based on total sleep period
(TSP), i.e., sleep period objectively deter-
mined by electroencephalographic re-
cordings between ﬁrst sleep onset and
ﬁnal awakening.
Overnight polysomnography re-
corded sleep and respiratory events ac-
cording to standard criteria. Sleep apnea
syndrome was deﬁned when apnea-
hypopnea index (AHI), i.e., number of
apneaplushypopneaperhour,wasabove
15 events/h (7).
Continuous glucose monitoring
(Medtronic, Minneapolis, MN) consisted
of a subcutaneous glucose-sensing device
with good correlation between blood and
subcutaneous glucose measurements (8).
A glucose level 150 mg/dl was consid-
ered hyperglycemia, and a glucose level
70mg/dlwasconsideredhypoglycemia
(9).
Quality of life was determined using
the diabetes quality of life (DQOL) ques-
tionnaire, as implemented during the Di-
abetes Control and Complications Trial
(10).
Statistical analysis
VariablesweredescribedbymeanandSD
or by frequency distribution. Normality
was analyzed by skewness and kurtosis
tests. Comparisons were made using Stu-
dent’s t or Mann-Whitney tests, depend-
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discrete variables, 
2 was used. Correla-
tionbetween1)TSPandday-nightSBPor
DBPand2)heartrate(HR),TSP,andtotal
sleep time (TST) was determined using
Pearson correlations, since data followed
normal distribution. Spearman correla-
tions were used between HR and noctur-
nal hypoglycemia, since data were not
normally distributed (NCSS statistical
software 1997; NCSS, Kaysville, UT).
RESULTS— Of the 20 participants, 9
dipper and 11 nondipper subjects were
identiﬁed. The two groups did not differ
in terms of anthropometrics (age 47  12
years, BMI 26.7  3.2 kg/m
2), diabetes
characteristics (A1C 8  1%, disease du-
ration 22  10 years, plasma creatinine
87  18 mol/l, urinary albumin excre-
tion 32  32 g/min), and 24-h mean
SBP (121  17 mmHg), DBP (79  9
mmHg), and HR (71  13 bpm).
Fifty-ﬁve percent of subjects exhib-
ited an obstructive sleep apnea syndrome
(AHI 22.6  18.2 events/h) without dif-
ference in terms of prevalence and sever-
ity between dippers and nondippers. TSP
and TST, i.e., the sum of all sleep periods
assessed by electroencephalogram, were
signiﬁcantly higher in dipper patients
(TSP 497  30 and 407  44 min, P 
0.001, TST 425  82 and 356  72 min,
P  0.03, for dippers and nondippers,
respectively).Sleeparchitecturetendedto
demonstrate more stages 1–2 and less
stages 3–4 and rapid eye movement
(REM) in nondipper patients (stage 1–2,
65  7 and 71  14%; stage 3–4, 13  6
and 9  8%; REM, 22  4 and 20  7%
for dippers and nondippers, respec-
tively, NS). SBP and DBP day-night dif-
ferences were signiﬁcantly correlated
with TSP (r  0.44 and r  0.49 for
SBP and DBP differences, respectively)
(Fig. 1).
Nocturnal hypoglycemia was more
frequent among dipper subjects (8.1 
10.7 and 0.1  0.4% of sleep time spent
in hypoglycemia for dippers and nondip-
pers, respectively, P  0.02). DQOL was
signiﬁcantly impaired in nondipper sub-
jects only for the treatment satisfaction
item (82.2  13.5 vs. 63.7  19.3 for
dippers and nondippers, respectively,
P  0.03).
Nocturnal mean HR was negatively
correlated with TSP (r  0.53), TST
(r  0.44), and time spent in hypogly-
cemia (r  0.56).
CONCLUSIONS— Sleep recordings,
BP measurements, and continuous glucose
monitoringwereusedtogetherintype1di-
abetic patients. Such a complexity explains
the relatively limited sample of patients in-
cluded. Polysomnography allowed for ob-
jectively deﬁning the beginning and end of
sleep and then an appropriate classiﬁcation
for dippers and nondippers (11).
To our knowledge, no study has ex-
plored the potential link between abnor-
mal nocturnal BP pattern and altered
sleep quality in type 1 diabetes. In our
work, shorter sleep duration explained
19–24% of the decrease in day-night BP
difference (r
2  0.19 and 0.24 for SBP
and DBP, respectively) and 28% of the
increase in HR (r
2  0.28). Outside the
scope of type 1 diabetes, general popula-
tion studies have demonstrated that short
sleep duration habits were associated
with increased risk of developing hyper-
tension (12).
We found a high prevalence of sleep
apneaamongourtype1diabeticsubjects.
Although sleep apnea is clearly related to
nondipping BP pattern (13), it was not an
independent explaining factor for non-
dipping in our population.
Hypoglycemia unawareness during
the night in type 1 diabetic patients is a
major concern in disease management.
Indeed, convulsions, neurologic afteref-
fects, and “dead-in-bed” syndrome have
beenreportedinthiscondition(14).Sub-
jectsfailtoawakewhenhypoglycemiaoc-
curs at night, in relation with blunted
counterregulatory epinephrine level (5).
Other studies suggest that unperceived
hypoglycemia occurred in patients with
more efﬁcient and more stage 3–4 sleep,
without sympathetic activation (15). In
our work, patients with dipping status,
longer sleep duration, and lower HR pre-
sented more unperceived hypoglycemia.
A more stable sleep, which is associated
with a lower sympathetic activation,
could explain these events.
Our study suggests that assessing
sleep duration is fully relevant in clinical
practice. BP nondipping status should re-
ceive particular attention in type 1 dia-
betic patients with short sleep duration,
and hypoglycemia unawareness deserves
careful prevention in patients with longer
and more stable sleep.
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